Related Experiment Video
Updated: Dec 21, 2025

Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
Preventing food allergy in infancy and childhood: Systematic review of randomised controlled trials
Debra de Silva1, Susanne Halken2, Chris Singh1
1The Evidence Centre Ltd, London, UK.
Insights
Preventing infant food allergies may involve early introduction of certain foods like egg and peanut. However, evidence for many other interventions, including dietary changes and supplements, is uncertain.
Area of Science:
- Allergy and Immunology
- Pediatric Nutrition
- Preventive Medicine
Background:
- Immediate-onset/IgE-mediated food allergy prevention strategies are crucial for public health.
- Guidelines by the European Academy of Allergy and Immunology (EAACI) require updated evidence.
- Understanding effective interventions is key to reducing the burden of food allergies.
Purpose of the Study:
- To systematically review interventions for preventing immediate-onset/IgE-mediated food allergy.
- To inform the development of new European Academy of Allergy and Immunology (EAACI) guidelines.
- To synthesize current evidence on the efficacy of various preventive strategies.
Main Methods:
- Systematic review utilizing the GRADE approach.
- Comprehensive search of eleven databases from 1946 to October 2019.
- Narrative synthesis of findings due to study heterogeneity in interventions, populations, and outcomes.
Main Results:
- Early introduction of well-cooked egg (4-6 months) likely reduces hen's egg allergy risk.
- Introducing peanut from 4-11 months probably significantly reduces peanut allergy risk in high-prevalence countries.
- Evidence for many interventions (dietary avoidance, supplements, probiotics, breastfeeding, hydrolyzed formulas) is very uncertain or suggests little to no effect.
Conclusions:
- Early introduction of specific allergens like egg and peanut shows promise in preventing allergies.
- Significant knowledge gaps remain in food allergy prevention, particularly regarding early allergen introduction.
- Further research is needed to validate findings in diverse populations and refine prevention guidelines.
Background:
This systematic review of ways to prevent immediate-onset/IgE-mediated food allergy will inform guidelines by the European Academy of Allergy and Immunology (EAACI).
Methods:
The GRADE approach was used. Eleven databases were searched from 1946 to October 2019 for randomized controlled trials (and large prospective cohort studies in the case of breastfeeding). The studies included heterogeneous interventions, populations, and outcomes and so were summarized narratively.
Results:
Forty-six studies examined interventions to reduce the risk of food allergy in infancy (up to 1 year) or early childhood. The following interventions for pregnant or breastfeeding women and/or infants may have little to no effect on preventing food allergy, but the evidence is very uncertain: dietary avoidance of food allergens, vitamin supplements, fish oil, probiotics, prebiotics, synbiotics, and emollients. Breastfeeding, hydrolyzed formulas, and avoiding cow's milk formula may not reduce the risk of cow's milk protein allergy; however, temporary supplementation with cow's milk formula in the first week of life may increase the risk of cow's milk allergy. Introducing well-cooked egg, but not pasteurized raw egg, from 4 to 6 months probably reduces the risk of hen's egg allergy. Introducing regular peanut consumption into the diet of an infant at increased risk beginning from 4 to 11 months probably results in a large reduction in peanut allergy in countries with a high prevalence. These conclusions about introducing peanut are based on moderate certainty evidence, from single trials in high-income countries.
Conclusions:
Sixty percent of the included studies were published in the last 10 years, but much still remains to be understood about preventing food allergy. In particular, there is a need to validate the potential benefits of early introduction of food allergens in a wider range of populations.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions
Drug Dosing: Infants and Children
Allergic Drug Reactions
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

